Picture of Anatara Lifesciences logo

ANR Anatara Lifesciences Balance Sheet

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Anatara Lifesciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments2.683.431.170.4010.982
Net Total Accounts Receivable
Net Total Receivables0.630.7730.50910.671
Total Other Current Assets
Total Current Assets3.344.241.71.421.67
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0070.0850.0670.0030.001
Net Intangible Assets
Total Assets3.344.331.771.421.67
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.4640.4030.3580.4940.304
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities0.4870.4970.4030.4950.307
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity2.863.831.360.9251.36
Total Liabilities & Shareholders' Equity3.344.331.771.421.67
Total Common Shares Outstanding